Ushma Wadia

559 total citations
19 papers, 251 citations indexed

About

Ushma Wadia is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Ushma Wadia has authored 19 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Ushma Wadia's work include Respiratory viral infections research (7 papers), Influenza Virus Research Studies (5 papers) and Immune responses and vaccinations (4 papers). Ushma Wadia is often cited by papers focused on Respiratory viral infections research (7 papers), Influenza Virus Research Studies (5 papers) and Immune responses and vaccinations (4 papers). Ushma Wadia collaborates with scholars based in Australia, United Kingdom and Spain. Ushma Wadia's co-authors include Peter Richmond, Jodie McVernon, Charmaine Gittleson, Terry Nolan, Helen Marshall, Stephen B. Lambert, Günter Härtel, Michael H. Lai, Michael E. Greenberg and Michael D. Nissen and has published in prestigious journals such as JAMA, PLoS ONE and Nutrients.

In The Last Decade

Ushma Wadia

18 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ushma Wadia Australia 7 196 88 60 38 25 19 251
Jaume Giménez Durán Spain 7 204 1.0× 57 0.6× 41 0.7× 25 0.7× 28 1.1× 21 257
Ian McGovern United States 10 280 1.4× 109 1.2× 30 0.5× 61 1.6× 12 0.5× 36 331
Cyril Jean‐Marie Martel Denmark 8 126 0.6× 60 0.7× 49 0.8× 28 0.7× 20 0.8× 22 217
José Luis Díaz‐Ortega Mexico 9 242 1.2× 108 1.2× 54 0.9× 168 4.4× 7 0.3× 29 333
Yang Feng Belgium 8 245 1.3× 58 0.7× 64 1.1× 27 0.7× 11 0.4× 19 285
Isabelle Daviaud France 8 277 1.4× 62 0.7× 18 0.3× 36 0.9× 27 1.1× 10 293
C. Hallie Phillips United States 5 237 1.2× 94 1.1× 23 0.4× 51 1.3× 21 0.8× 8 284
Bettie Voordouw Netherlands 8 166 0.8× 57 0.6× 25 0.4× 31 0.8× 5 0.2× 9 235
Valentino Tisa Italy 6 148 0.8× 41 0.5× 19 0.3× 54 1.4× 8 0.3× 9 187
Catherine Thompson United Kingdom 5 231 1.2× 58 0.7× 23 0.4× 34 0.9× 28 1.1× 5 245

Countries citing papers authored by Ushma Wadia

Since Specialization
Citations

This map shows the geographic impact of Ushma Wadia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ushma Wadia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ushma Wadia more than expected).

Fields of papers citing papers by Ushma Wadia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ushma Wadia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ushma Wadia. The network helps show where Ushma Wadia may publish in the future.

Co-authorship network of co-authors of Ushma Wadia

This figure shows the co-authorship network connecting the top 25 collaborators of Ushma Wadia. A scholar is included among the top collaborators of Ushma Wadia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ushma Wadia. Ushma Wadia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lamichhane, Binit, Cara Minney–Smith, Ushma Wadia, et al.. (2025). Respiratory Syncytial Virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab Prophylaxis. Open Forum Infectious Diseases. 12(8). ofaf429–ofaf429. 1 indexed citations
2.
Wadia, Ushma, Hannah C. Moore, Peter Richmond, et al.. (2025). Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024. Journal of Infection. 90(4). 106466–106466. 10 indexed citations
3.
Bloomfield, Lauren, Nevada Pingault, Rachel E. Foong, et al.. (2025). Nirsevimab immunisation of infants and respiratory syncytial virus (RSV)‐associated hospitalisations, Western Australia, 2024: a population‐based analysis. The Medical Journal of Australia. 222(11). 568–570. 5 indexed citations
5.
Foley, David A., Cara Minney–Smith, Briony Hazelton, et al.. (2023). Respiratory Syncytial Virus Reinfections in Children in Western Australia. Viruses. 15(12). 2417–2417. 8 indexed citations
6.
McLeod, Charlie, Katie L. Flanagan, Magdalena Plebanski, et al.. (2023). Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO). Trials. 24(1). 202–202. 4 indexed citations
7.
Villanueva, Paola, Nigel W. Crawford, Mariana Garcia Croda, et al.. (2023). Safety of BCG vaccination and revaccination in healthcare workers. Human Vaccines & Immunotherapeutics. 19(2). 2239088–2239088. 2 indexed citations
8.
Villanueva, Paola, Nigel W. Crawford, Mariana Garcia Croda, et al.. (2023). Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination. Heliyon. 9(4). e15241–e15241. 2 indexed citations
9.
Norman, Daniel, Margie Danchin, Christopher C. Blyth, et al.. (2022). Australian hospital paediatricians and nurses’ perspectives and practices for influenza vaccine delivery in children with medical comorbidities. PLoS ONE. 17(12). e0277874–e0277874. 1 indexed citations
10.
Villanueva, Paola, Ushma Wadia, Nigel W. Crawford, et al.. (2022). The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines. PLoS ONE. 17(6). e0268042–e0268042. 3 indexed citations
11.
Villanueva, Paola, Ushma Wadia, Nigel W. Crawford, et al.. (2022). Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy. npj Vaccines. 7(1). 6–6. 11 indexed citations
12.
Deng, Lucy, Margie Danchin, Georgina Lewis, et al.. (2022). Status epilepticus following vaccination in children aged ≤24 months: A five-year retrospective observational study. Epilepsy & Behavior. 128. 108579–108579. 4 indexed citations
13.
Deng, Lucy, Margie Danchin, Georgina Lewis, et al.. (2021). Revaccination outcomes of children with vaccine proximate seizures. Vaccine. 39(11). 1565–1571. 6 indexed citations
14.
Ryan, Anne L., Ushma Wadia, Peter Jacoby, et al.. (2019). Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant. Bone Marrow Transplantation. 55(4). 773–779. 6 indexed citations
16.
McLeod, Charlie, Daniel K. Yeoh, Christopher C. Blyth, et al.. (2017). A 15-Year Old Burmese Girl With Hemoptysis: A Case Report. Open Forum Infectious Diseases. 4(4). ofx224–ofx224. 1 indexed citations
17.
Kotecha, Rishi S., Ushma Wadia, Peter Jacoby, et al.. (2015). Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer. Cancer Medicine. 5(2). 285–293. 14 indexed citations
19.
Nolan, Terry, Jodie McVernon, Maryanne Skeljo, et al.. (2009). Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children. JAMA. 303(1). 37–37. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026